Moderna’s Strategic Pivot: Employee Stock Options as Retention Tool

As Moderna navigates its challenging transition beyond pandemic-era vaccine dominance, the biotechnology firm has secured overwhelming shareholder approval for a specialized employee stock option exchange program. This decisive move represents a critical effort to retain top talent during a period of significant transformation for the company.

The timing of this initiative is particularly noteworthy given Moderna’s recent market performance. Company shares experienced a substantial 6% decline just one day prior to the announcement and have faced persistent downward pressure throughout the current year. The newly authorized program enables employees to exchange underwater stock options—those with exercise prices above current trading levels—for new grants with more realistic strike prices. This strategic Read more...